ESCRS - Ocular Surface Diseases

Ocular Surface Diseases

Ocular Surface Diseases
Dry eye disease (DED) is an important problem for patients and their eye care providers because it can affect daily function, quality of life, vision and the outcomes of cataract and refractive surgery. It is also significant because it is a common condition in populations around the world. Dry eye disease seems to be increasing in response to local alterations already present in the eye, systemic diseases and external factors like poor air quality, high pollution and, even, changes in climate. This affects quality of life causing a disruption of a healthy microenvironment at the ocular surface. Studies investigating the epidemiology of DED report a wide range of prevalence rates, which may be explained in part by the use of different definitions. According to available data, however, as many as 33% to 40% of adults have dry eye symptoms. Importantly, findings of studies evaluating signs of DED (eg., tear film breakup time and tear volume) suggest there are individuals with dry eye who are not aware of their condition. Understanding the risk factors for DED, its possible etiologies, and the pathophysiologic mechanisms by which it develops and progresses can help clinicians as they approach the diagnosis and management of this condition. When evaluating patients for DED, it is also important to consider that other ocular surface diseases with overlapping signs and symptoms can mimic DED, but may coexist with and exacerbate DED. Clearly, unravelling the root causes of DED is required for successful treatment. Lately, there have been exciting developments in terms of understanding the pathophysiology of DED as well as for improving diagnosis and management. In this program, a renowned international faculty of DED experts provide an update on recent and forthcoming advances and share pearls for clinical practice. Download Supplement - click here
Tags: ocular pathology
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...